TFRC and brain neoplasm: This may be explained by the brain metastatic capacity of these cells and the fact that our anti-TfR1 antibodies do not cross-react with mouse TfR1 [34] and thus do not cross the blood-brain barrier that blocks accessibility to brain tumors.